Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid β and impairment of learning and memory

Li Bo Zou, Akihiro Mouri, Nobuhisa Iwata, Takaomi C. Saido, Dayong Wang, Min Wei Wang, Hiroyuki Mizoguchi, Yukihiro Noda, Toshitaka Nabeshima

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

An imbalance between anabolism and catabolism causes an accumulation of amyloid β-peptide (Aβ), which is a proposed trigger of the onset of Alzheimer's disease. Neprilysin is a rate-limiting peptidase that participates in the catabolism of Aβ in the brain. We examined whether rats continuously infused with thiorphan, a specific neprilysin inhibitor, into the hippocampus develop cognitive impairments through accumulation of Aβ. Thiorphan infusion elevated hippocampal Aβ40 and Aβ42 levels in the insoluble but not the soluble fraction. Thiorphan-infused rats displayed cognitive impairments in the ability to discriminate in the object recognition test, associative learning in the conditioned fear learning test, and spatial memory in the water maze test, tasks that depend on the hippocampus. These cognitive abilities in the battery of behavioral tasks inversely correlated with insoluble Aβ contents in the hippocampus. The nicotine-stimulated release of acetylcholine in the hippocampus of thiorphan-infused rats was significantly lower than that in vehicle-infused rats. These results indicate that continuous infusion of thiorphan into the hippocampus causes cognitive dysfunction and reduces cholinergic activity by raising the level of Aβ in the hippocampus and suggest that a reduction of neprilysin activity contributes to the deposition of Aβ and development of Alzheimer's disease.

Original languageEnglish
Pages (from-to)334-340
Number of pages7
JournalJournal of Pharmacology and Experimental Therapeutics
Volume317
Issue number1
DOIs
Publication statusPublished - 01-04-2006

Fingerprint

Thiorphan
Neprilysin
Amyloid
Hippocampus
Learning
Aptitude
Alzheimer Disease
Nicotine
Cholinergic Agents
Acetylcholine
Fear
Inhibition (Psychology)
Peptide Hydrolases
Water
Brain

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

Cite this

Zou, Li Bo ; Mouri, Akihiro ; Iwata, Nobuhisa ; Saido, Takaomi C. ; Wang, Dayong ; Wang, Min Wei ; Mizoguchi, Hiroyuki ; Noda, Yukihiro ; Nabeshima, Toshitaka. / Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid β and impairment of learning and memory. In: Journal of Pharmacology and Experimental Therapeutics. 2006 ; Vol. 317, No. 1. pp. 334-340.
@article{67c47f565d6549868cb4db5865a029fb,
title = "Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid β and impairment of learning and memory",
abstract = "An imbalance between anabolism and catabolism causes an accumulation of amyloid β-peptide (Aβ), which is a proposed trigger of the onset of Alzheimer's disease. Neprilysin is a rate-limiting peptidase that participates in the catabolism of Aβ in the brain. We examined whether rats continuously infused with thiorphan, a specific neprilysin inhibitor, into the hippocampus develop cognitive impairments through accumulation of Aβ. Thiorphan infusion elevated hippocampal Aβ40 and Aβ42 levels in the insoluble but not the soluble fraction. Thiorphan-infused rats displayed cognitive impairments in the ability to discriminate in the object recognition test, associative learning in the conditioned fear learning test, and spatial memory in the water maze test, tasks that depend on the hippocampus. These cognitive abilities in the battery of behavioral tasks inversely correlated with insoluble Aβ contents in the hippocampus. The nicotine-stimulated release of acetylcholine in the hippocampus of thiorphan-infused rats was significantly lower than that in vehicle-infused rats. These results indicate that continuous infusion of thiorphan into the hippocampus causes cognitive dysfunction and reduces cholinergic activity by raising the level of Aβ in the hippocampus and suggest that a reduction of neprilysin activity contributes to the deposition of Aβ and development of Alzheimer's disease.",
author = "Zou, {Li Bo} and Akihiro Mouri and Nobuhisa Iwata and Saido, {Takaomi C.} and Dayong Wang and Wang, {Min Wei} and Hiroyuki Mizoguchi and Yukihiro Noda and Toshitaka Nabeshima",
year = "2006",
month = "4",
day = "1",
doi = "10.1124/jpet.105.095687",
language = "English",
volume = "317",
pages = "334--340",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid β and impairment of learning and memory. / Zou, Li Bo; Mouri, Akihiro; Iwata, Nobuhisa; Saido, Takaomi C.; Wang, Dayong; Wang, Min Wei; Mizoguchi, Hiroyuki; Noda, Yukihiro; Nabeshima, Toshitaka.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 317, No. 1, 01.04.2006, p. 334-340.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid β and impairment of learning and memory

AU - Zou, Li Bo

AU - Mouri, Akihiro

AU - Iwata, Nobuhisa

AU - Saido, Takaomi C.

AU - Wang, Dayong

AU - Wang, Min Wei

AU - Mizoguchi, Hiroyuki

AU - Noda, Yukihiro

AU - Nabeshima, Toshitaka

PY - 2006/4/1

Y1 - 2006/4/1

N2 - An imbalance between anabolism and catabolism causes an accumulation of amyloid β-peptide (Aβ), which is a proposed trigger of the onset of Alzheimer's disease. Neprilysin is a rate-limiting peptidase that participates in the catabolism of Aβ in the brain. We examined whether rats continuously infused with thiorphan, a specific neprilysin inhibitor, into the hippocampus develop cognitive impairments through accumulation of Aβ. Thiorphan infusion elevated hippocampal Aβ40 and Aβ42 levels in the insoluble but not the soluble fraction. Thiorphan-infused rats displayed cognitive impairments in the ability to discriminate in the object recognition test, associative learning in the conditioned fear learning test, and spatial memory in the water maze test, tasks that depend on the hippocampus. These cognitive abilities in the battery of behavioral tasks inversely correlated with insoluble Aβ contents in the hippocampus. The nicotine-stimulated release of acetylcholine in the hippocampus of thiorphan-infused rats was significantly lower than that in vehicle-infused rats. These results indicate that continuous infusion of thiorphan into the hippocampus causes cognitive dysfunction and reduces cholinergic activity by raising the level of Aβ in the hippocampus and suggest that a reduction of neprilysin activity contributes to the deposition of Aβ and development of Alzheimer's disease.

AB - An imbalance between anabolism and catabolism causes an accumulation of amyloid β-peptide (Aβ), which is a proposed trigger of the onset of Alzheimer's disease. Neprilysin is a rate-limiting peptidase that participates in the catabolism of Aβ in the brain. We examined whether rats continuously infused with thiorphan, a specific neprilysin inhibitor, into the hippocampus develop cognitive impairments through accumulation of Aβ. Thiorphan infusion elevated hippocampal Aβ40 and Aβ42 levels in the insoluble but not the soluble fraction. Thiorphan-infused rats displayed cognitive impairments in the ability to discriminate in the object recognition test, associative learning in the conditioned fear learning test, and spatial memory in the water maze test, tasks that depend on the hippocampus. These cognitive abilities in the battery of behavioral tasks inversely correlated with insoluble Aβ contents in the hippocampus. The nicotine-stimulated release of acetylcholine in the hippocampus of thiorphan-infused rats was significantly lower than that in vehicle-infused rats. These results indicate that continuous infusion of thiorphan into the hippocampus causes cognitive dysfunction and reduces cholinergic activity by raising the level of Aβ in the hippocampus and suggest that a reduction of neprilysin activity contributes to the deposition of Aβ and development of Alzheimer's disease.

UR - http://www.scopus.com/inward/record.url?scp=33645114238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645114238&partnerID=8YFLogxK

U2 - 10.1124/jpet.105.095687

DO - 10.1124/jpet.105.095687

M3 - Article

C2 - 16382024

AN - SCOPUS:33645114238

VL - 317

SP - 334

EP - 340

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -